• Mashup Score: 6
    Sinus of Valsalva Aneurysms—47 Years of a Single Center Experience and Systematic Overview of Published Reports - 2 year(s) ago

    A retrospective study was undertaken to review demographic data, clinical presentation, outcomes, and long-term results of surgical repair of sinus of Valsalva aneurysms (SVAs). SVAs are a rare anomaly. Surgery is the treatment of choice. A retrospective review of an institutional database identified 86 patients who underwent SVA repair from 1956 to 2003. Follow-up ranged from 3 months to 40…

    Source: American Journal of Cardiology
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of EGarciaSayan
      EGarciaSayan

      #ASEchoJC 🔺En serie de Mayo Clinic: aneurismas del SV derecho 70% (usualmente fistula al VD), no-coronario 25% (usualmente fistula a AD), izquierdo es poco común (5%~) 🔺Edad media 45, 63% masculino 👉Am J Cardiol 2007; 99: pp. 1159-1164: https://t.co/P4nP2yiRDD https://t.co/ioaRSUGNbe https://t.co/CP5nryMZei

    • Profile photo of EGarciaSayan
      EGarciaSayan

      #ASEchoJC 💥Large single-center (Mayo) series: 🔺RSOVA 70% (most common fistula to RV), NCSOVA 25% (most common fistula to RA), LCSOVA less common (5%~) 🔺Median age 45, 63% male 👉Am J Cardiol 2007; 99: pp. 1159-1164: https://t.co/P4nP2yiRDD https://t.co/eYCPFjrBIZ https://t.co/hxaHvJs7Zh

  • Mashup Score: 0
    PROFESSOR Sir Magdi Habib Yacoub, FRS, FRCS, FRCP, DS: a conversation with the editor * - 2 year(s) ago

    Sir Magdi Yacoub was born on November 16, 1935 in Belbais, Egypt. He grew up in several different small towns or villages in Egypt. At age 15, he entered the University of Cairo College of Medicine on a full scholarship. Following a rotating internship at Cairo University Hospital, he did 2 years residency in general surgery at the same institution and then went to London, where he did his…

    Source: American Journal of Cardiology
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Hragy
      Hragy

      PROFESSOR Sir Magdi Habib Yacoub, FRS, FRCS, FRCP, DS: a conversation with the editor* - American Journal of Cardiology https://t.co/M4wVBBHt1M

  • Mashup Score: 0
    Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis - 2 year(s) ago

    Impella was approved by the Food and Drug Administration in 2015 for use during high-risk percutaneous coronary interventions (PCIs); however, its safety and efficacy compared with intra-aortic balloon pump (IABP) has not been evaluated in contemporary practice and remains debated. We aimed to compare postapproval outcomes and costs of Impella versus IABP support for high-risk PCI in real-world…

    Source: American Journal of Cardiology
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HanCardiomd
      HanCardiomd

      This study from the @Yale demonstrates significant survival benefit in high-risk PCI with #Impella support In-🏥 survival was significantly ⤴️ with Impella compared to #IABP (unadjusted 95.3% vs. 91.0%, p=0.0002; adjusted OR 1.55, 95% CI 1.02, 2.36) https://t.co/hwoejkdijO https://t.co/wNldFylqaH

  • Mashup Score: 0
    Trends and Outcomes of Transcatheter Aortic Valve Implantation in Hypertrophic Cardiomyopathy - 2 year(s) ago

    The landmark clinical trials on the utility of transcatheter aortic valve implantation (TAVI) excluded patients with hypertrophic cardiomyopathy (HCM) and concomitant severe aortic stenosis.1 TAVI in HCM presents unique technical or physiologic challenges called “suicide left ventricle,” that is, sudden reduction in afterload after TAVI exacerbates subvalvular obstruction, which leads to…

    Source: American Journal of Cardiology
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of YevgeniyBr
      YevgeniyBr

      Great cases! Congratulations to the authors for tackling these complex patients. We also recently explored this topic. @IRajapreyar @vakasullah @Matt_DiMeglio @AVishnevsky_MD @TJHeartFellows @JeffIMchiefs https://t.co/btPBa78zaZ https://t.co/UyhxgVHkXo

  • Mashup Score: 0
    Impact of QRS Duration on Non–ST-Segment Elevation Myocardial Infarction (from a National Registry) - 2 year(s) ago

    QRS duration (QRSd) is ill-defined and under-researched as a prognosticator in patients with non–ST-segment myocardial infarction (NSTEMI). We analyzed 240,866 adult (≥18 years) hospitalizations with non–ST-segment elevation myocardial infarction using data from the United Kingdom Myocardial Infarction National Audit Project. Clinical characteristics and all-cause in-hospital mortality were…

    Source: American Journal of Cardiology
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mmamas1973
      mmamas1973

      Our analysis of Impact of QRS Duration on Non–ST-Segment Elevation Myocardial Infarction (from a National Registry) led by @MoledinaSM with @fischman_david @islamelgendy83 @Ayman_Elbadawi_ https://t.co/knfs7b9hLj

  • Mashup Score: 3
    Myopericarditis After COVID-19 Booster Dose Vaccination - 2 year(s) ago

    COVID-19 vaccine boosters were recommended by the Centers for Disease Control (CDC) for all populations ≥18 years to provide better protection against circulating variants. The risk of myopericarditis after sequential COVID-19 vaccination needs to be evaluated. We have demonstrated that the Vaccine Safety Datalink rapid cycle analysis method identified a lower incidence of myopericarditis after…

    Source: American Journal of Cardiology
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of TracyBethHoeg
      TracyBethHoeg

      One of the best estimates we have on post-mRNA vax booster myocarditis in males was 1/6800 males 18/39 https://t.co/NSMQGCksil

Load More